SLITRK4
SLIT and NTRK-like protein 4
Also known as: DKFZp547M2010, SLIK4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IW52
- Gene
- SLITRK4
- Ensembl
- ENSG00000179542
- Chromosome
- X
- Canonical length
- 837 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a transmembrane protein belonging to the the SLITRK family. These family members include two N-terminal leucine-rich repeat domains similar to those found in the axonal growth-controlling protein SLIT, as well as C-terminal regions similar to neurotrophin receptors. Studies of an homologous protein in mouse suggest that this family member functions to suppress neurite outgrowth. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
837 residues, UniProt reviewed canonical sequence.
>Q8IW52|SLITRK4
1 MFLWLFLILS ALISSTNADS DISVEICNVC SCVSVENVLY VNCEKVSVYR PNQLKPPWSN
61 FYHLNFQNNF LNILYPNTFL NFSHAVSLHL GNNKLQNIEG GAFLGLSALK QLHLNNNELK
121 ILRADTFLGI ENLEYLQADY NLIKYIERGA FNKLHKLKVL ILNDNLISFL PDNIFRFASL
181 THLDIRGNRI QKLPYIGVLE HIGRVVELQL EDNPWNCSCD LLPLKAWLEN MPYNIYIGEA
241 ICETPSDLYG RLLKETNKQE LCPMGTGSDF DVRILPPSQL ENGYTTPNGH TTQTSLHRLV
301 TKPPKTTNPS KISGIVAGKA LSNRNLSQIV SYQTRVPPLT PCPAPCFCKT HPSDLGLSVN
361 CQEKNIQSMS ELIPKPLNAK KLHVNGNSIK DVDVSDFTDF EGLDLLHLGS NQITVIKGDV
421 FHNLTNLRRL YLNGNQIERL YPEIFSGLHN LQYLYLEYNL IKEISAGTFD SMPNLQLLYL
481 NNNLLKSLPV YIFSGAPLAR LNLRNNKFMY LPVSGVLDQL QSLTQIDLEG NPWDCTCDLV
541 ALKLWVEKLS DGIVVKELKC ETPVQFANIE LKSLKNEILC PKLLNKPSAP FTSPAPAITF
601 TTPLGPIRSP PGGPVPLSIL ILSILVVLIL TVFVAFCLLV FVLRRNKKPT VKHEGLGNPD
661 CGSMQLQLRK HDHKTNKKDG LSTEAFIPQT IEQMSKSHTC GLKESETGFM FSDPPGQKVV
721 MRNVADKEKD LLHVDTRKRL STIDELDELF PSRDSNVFIQ NFLESKKEYN SIGVSGFEIR
781 YPEKQPDKKS KKSLIGGNHS KIVVEQRKSE YFELKAKLQS SPDYLQVLEE QTALNKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLITRK4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 9.8 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 9.8 nTPM
- cerebellum: 9.6 nTPM
- skeletal muscle: 7.1 nTPM
- cerebral cortex: 6.7 nTPM
- cervix: 4.8 nTPM
- hippocampal formation: 4.4 nTPM
Single-cell type
- adrenal cortex cells: 79 nCPM
- leydig cells: 64 nCPM
- brain excitatory neurons: 49 nCPM
- brain inhibitory neurons: 47 nCPM
- oligodendrocyte progenitor cells: 36 nCPM
- thymic myoid cells: 33 nCPM
Immune cell
- basophil: 12 nTPM
- classical monocyte: 4.1 nTPM
- myeloid DC: 3.2 nTPM
- non-classical monocyte: 2.7 nTPM
- intermediate monocyte: 2.5 nTPM
- total PBMC: 0.9 nTPM
Brain region
- cerebellum: 32 nTPM
- cerebral cortex: 31 nTPM
- basal ganglia: 26 nTPM
- hippocampal formation: 23 nTPM
- hypothalamus: 17 nTPM
- white matter: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.79
- gnomAD missense Z
- 1.97
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- axonogenesis
- behavioral fear response
- cell population proliferation
- long-term synaptic potentiation
- memory
- positive regulation of synapse assembly
- regulation of synapse organization
- smoothened signaling pathway
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLITRK4 as an antibody target. Whether an autoantibody or antibody against SLITRK4 could matter depends on whether native SLITRK4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLITRK4 is annotated at the cell surface, where native SLITRK4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLITRK4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...